Phio Pharmaceuticals Corp. (PHIO)
1.13
+0.01
(+0.89%)
USD |
NASDAQ |
Aug 28, 16:00
1.12
-0.01
(-0.88%)
After-Hours: 20:00
Phio Pharmaceuticals Free Cash Flow : -12.21M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -12.21M |
| March 31, 2026 | -10.72M |
| December 31, 2025 | -7.991M |
| September 30, 2025 | -7.284M |
| June 30, 2025 | -7.145M |
| March 31, 2025 | -6.379M |
| December 31, 2024 | -7.113M |
| September 30, 2024 | -8.111M |
| June 30, 2024 | -9.058M |
| March 31, 2024 | -10.06M |
| December 31, 2023 | -10.75M |
| September 30, 2023 | -11.09M |
| June 30, 2023 | -11.72M |
| March 31, 2023 | -11.38M |
| December 31, 2022 | -12.25M |
| September 30, 2022 | -12.02M |
| June 30, 2022 | -11.61M |
| March 31, 2022 | -12.44M |
| December 31, 2021 | -11.91M |
| September 30, 2021 | -12.06M |
| June 30, 2021 | -10.91M |
| March 31, 2021 | -9.674M |
| December 31, 2020 | -8.821M |
| September 30, 2020 | -8.738M |
| June 30, 2020 | -8.811M |
| Date | Value |
|---|---|
| March 31, 2020 | -8.727M |
| December 31, 2019 | -8.717M |
| September 30, 2019 | -7.927M |
| June 30, 2019 | -7.882M |
| March 31, 2019 | -7.794M |
| December 31, 2018 | -7.525M |
| September 30, 2018 | -7.975M |
| June 30, 2018 | -8.18M |
| March 31, 2018 | -8.823M |
| December 31, 2017 | -9.717M |
| September 30, 2017 | -8.89M |
| June 30, 2017 | -8.283M |
| March 31, 2017 | -7.64M |
| December 31, 2016 | -7.764M |
| September 30, 2016 | -7.99M |
| June 30, 2016 | -8.348M |
| March 31, 2016 | -8.319M |
| December 31, 2015 | -7.374M |
| September 30, 2015 | -7.378M |
| June 30, 2015 | -7.196M |
| March 31, 2015 | -7.453M |
| December 31, 2014 | -7.853M |
| September 30, 2014 | -7.719M |
| June 30, 2014 | -7.671M |
| March 31, 2014 | -7.641M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Imunon, Inc. | -15.18M |
| Agenus, Inc. | -98.50M |
| Amgen, Inc. | 10.18B |
| Anika Therapeutics, Inc. | 0.562M |
| BioCryst Pharmaceuticals, Inc. | 356.23M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.035M |
| Free Cash Flow Per Share (Quarterly) | -0.3473 |
| Free Cash Flow to Equity (Quarterly) | -4.035M |
| Free Cash Flow to Firm (Quarterly) | -4.035M |
| Free Cash Flow Yield | -107.2% |